[1]陈雅桐,贺红安,周旭,等.基于网络药理学探讨柴胡桂枝干姜汤治疗腺样体肥大的作用机制[J].西部中医药,2024,37(02):116-121.[doi:10.12174/j.issn.2096-9600.2024.02.22]
　CHEN Yatong,HE Hongan,ZHOU Xu,et al.Network Pharmacology-based Discussion into the Mechanism of the Treatment of Adenoid Hypertrophy by Chaihu Guizhi Ganjiang Tang[J].Western Journal of Traditional Chinese Medicine,2024,37(02):116-121.[doi:10.12174/j.issn.2096-9600.2024.02.22]
点击复制

基于网络药理学探讨柴胡桂枝干姜汤治疗腺样体肥大的作用机制

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年02期
页码:
116-121
栏目:
二次研究
出版日期:
2024-02-15

文章信息/Info

Title:
Network Pharmacology-based Discussion into the Mechanism of the Treatment of Adenoid Hypertrophy by Chaihu Guizhi Ganjiang Tang
作者:
陈雅桐1, 贺红安2, 周旭3, 张葆青3
1.山东中医药大学，山东 济南 250014
2.山东中医药大学博士后流动站，山东 济南 250355
3.山东中医药大学附属医院，山东 济南 250014
Author(s):
CHEN Yatong1, HE Hong′an2, ZHOU Xu3, ZHANG Baoqing3
1.Shandong University of Traditional Chinese Medicine, Jinan 250014, China
2.Postdoctoral Research Station, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
3.Affiliated Hospital of Shandong University of Traditional Chi
关键词:
腺样体肥大; 柴胡桂枝干姜汤; 网络药理学
Keywords:
adenoid hypertrophy; network pharmacology
分类号:
R856.76
DOI:
10.12174/j.issn.2096-9600.2024.02.22
文献标志码:
A
摘要:
目的基于网络药理学探讨柴胡桂枝干姜汤治疗腺样体肥大的作用机制。 方法通过中药系统药理学数据库与分析平台（traditional Chinese medicinesystems pharmacology database and analysis platform，TCMSP），BATMAN-TCM数据库结合口服利用度（oral bioavailability，OB）、类药性（drug-likeness，DL），药物半衰期（drug half-life，HL）检索柴胡桂枝干姜汤中柴胡、桂枝、干姜、黄芩、瓜蒌根、牡蛎、炙甘草的候选化合物及作用靶点信息，并通过Uniprot数据库将靶点校正为基因名；运用Genecards数据库获取腺样体肥大的相关靶点与基因，利用VENNY图获得柴胡桂枝干姜汤与腺样体肥大的交集靶点；STRING数据库来构建蛋白质相互作用PPI网络图；David数据库对交集靶点进行基因本体（gene ontology，GO）功能富集分析和KEGG通路富集分析；Cytoscape软件进行网络靶点特性分析。 结果筛选出柴胡桂枝干姜汤候选化合物65个，转化为有效靶点288个，得到腺样体肥大相关靶点781个，匹配得到共有靶点118个。GO富集主要涉及597个生物学过程、60个细胞组成和106个分子功能，KEGG通路分析主要涉及112条通路。 结论柴胡桂枝干姜汤治疗腺样体肥大是通过多靶点多通路发挥作用的。
Abstract:
ObjectiveTo explore the mechanism of treating adenoid hypertrophy by Chaihu Guizhi Ganjiang Tang based on network pharmacology. MethodsTCMSP and BATMAN-TCM databases were used in combina-tion with OB, DL and HL, to search for candidate compounds and targets of Chaihu (Bupleuri radix), Guizhi(Cinnamomi ramulus), dried ginger, Huangqin(Scutellariae radix), Tianhuafen(Trichosanthis radix), Muli (Ostreae concha) and Zhigancao(Glycyrrhizae radix et rhizoma praeparata cum melle) in the decoction, and the targets were corrected to the names of genes via the Uniprot database; Genecards was applied to obtain the targets and genes related to adenoid hypertrophy, Venny diagram was utilized to obtain the intersection targets of Chaihu Guizhi Ganjiang Tang and adenoid hypertrophy; STRING database to construct PPI network of protein interaction; David database to perform GO function enrichment analysis and KEGG enrichment analysis of the intersection targets; Cytoscape software to analyze the characteristics of network targets. ResultsAll 65 candidate compounds of Chaihu Guizhi Ganjiang Tang were screened out, and transformed into 288 active targets, obtaining 781 adenoid hypertrophy-related targets and 118 common targets matched. GO enrichment mainly involved 597 biological processes, 60 cellular compositions and 106 molecular functions, and KEGG pathway analysis mainly dealt with 112 pathways. ConclusionTreatment of adenoid hypertrophy by Chaihu Guizhi Ganjiang Tang could develop the effects by multi-target and multi-pathway.

相似文献/References:

[1]张慧君.柴胡桂枝干姜汤治疗肝郁脾虚型胃食管反流病临床观察[J].西部中医药,2025,38(11):122.[doi:10.12174/j.issn.2096-9600.2025.11.21]
　ZHANG Huijun.Clinical Observation on Chaihu Guizhi Dried Ginger Decoction in the Treatment of Gastroesophageal Reflux Disease of Liver Depression and Spleen Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2025,38(02):122.[doi:10.12174/j.issn.2096-9600.2025.11.21]
[2]宋李华,李先海,王程.中医踩跷联合柴胡桂枝干姜汤治疗慢性疲劳综合征临床观察[J].西部中医药,2021,34(05):133.[doi:10.12174/j.issn.2096-9600.2021.05.34]
　SONG Lihua,LI Xianhai,WANG Cheng.Clinical Observation on Treating Chronic Fatigue Syndrome by TCM Stilt-walking Combined with Chaihu Guizhi Ganjiang Decoction[J].Western Journal of Traditional Chinese Medicine,2021,34(02):133.[doi:10.12174/j.issn.2096-9600.2021.05.34]

备注/Memo

备注/Memo:
陈雅桐（1996—），女，硕士学位。研究方向：小儿神经精神行为疾病和呼吸系统疾病的中医药治疗。国家中医药管理局中医药循证能力建设项目（2019XZZX-EK004）。
更新日期/Last Update: 2024-02-15